{"@id":"https://bioecon.ru/technology/adc-linker-chemistry/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/adc-linker-chemistry/","json":"https://cn.bioecon.ru/api/v1/technology/adc-linker-chemistry/index.json"},"id":"adc-linker-chemistry","industries":["pharma"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/linium-biochemicals/","https://bioecon.ru/companies/recursion-pharmaceuticals/","https://bioecon.ru/companies/fermbox-bio/","https://bioecon.ru/companies/proklean-technologies-pvt-ltd/","https://bioecon.ru/companies/pili/"]},"maturity":null,"name":"ADC 连接子化学","regions":["us","cn","eu"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-09-18","entity":"wuxi-xdc","kind":"vendor","urls":["https://www.leadingir.com/datacenter/view/11886.html","https://www.wuxixdc.com/en/"]},{"date":"2026-09-18","entity":"sutro-biopharma","kind":"vendor","urls":["https://ir.sutrobio.com/financials/sec-filings/content/0001193125-26-119873/stro-20251231.htm","https://www.pharmamanufacturing.com/all-articles/article/55277392/sutro-to-exit-internal-gmp-manufacturing-facility-by-end-of-2025-as-part-of-restructuring","https://www.sec.gov/Archives/edgar/data/1382101/000119312526224170/R11.htm","https://www.sutrobio.com/sutro-biopharma-and-boehringer-ingelheim-bioxcellence-collaboration-established-first-in-class-cell-free-capabilities-at-commercial-scale/","https://www.sutrobio.com/wp-content/uploads/2020/09/World-ADC-Shabbir-Anik-Sutro-FINAL-compressed.pdf"]},{"date":"2026-09-18","entity":"remegen","kind":"vendor","urls":["https://hk-official.cmbi.info/upload/32ccc4b2-b96f-41fb-8fdd-eabf3c425fb1.pdf","https://ir.vorbio.com/news-releases/news-release-details/vor-bio-enters-exclusive-global-license-agreement-remegen-late","https://pdf.dfcfw.com/pdf/H3_AP202211041579914299_1.pdf","https://quartr.com/events/remegen-co-ltd-9995-q2-2026_F1LMGYsM","https://www.hkexnews.hk/listedco/listconews/sehk/2026/0824/2026082401967.pdf","https://www.remegen.com/uploadfile/2025/12/10/1852a7b04bedcee16d58b298637feee16938bb5d48934.pdf","https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800854.pdf"]}],"stages":[{"n":1,"title":"抗体生产"},{"n":2,"title":"载荷-连接子 GMP"},{"n":3,"title":"偶联"},{"n":4,"title":"分析与批放行"},{"n":5,"title":"灌装"},{"n":6,"title":"多区域供应"}],"summary":"把抗体变成载荷递送载体的偶联化学——可裂解连接子、位点特异性偶联与高活性载荷生产。表格收录三家台账全溯源的供应商；行业更宽的 CDMO 层在注记中点名，而非充数进表。","url":"/technology/adc-linker-chemistry/","verified":"2026-09-18"}